Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.58 |
| ▸ | SNCA | P37840 | 3/20 | 0.51 |
| ▸ | BCHE | P06276 | 12/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 3/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.37 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.37 |
| ▸ | HTR2A | P28223 | 1/20 | 0.37 |
| ▸ | HTR2C | P28335 | 1/20 | 0.37 |
| ▸ | DRD3 | P35462 | 1/20 | 0.37 |
| ▸ | HTR2B | P41595 | 1/20 | 0.37 |
| ▸ | HTR6 | P50406 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29776881 | 0.80 | SNCA (0.73) | NOX1SNCABCHEMEN1MAPK1 | |
| SCHEMBL5452710 | 0.80 | SNCA (0.73) | NOX1SNCABCHEMEN1MAPK1 | |
| SCHEMBL1208165 | 0.79 | NOX1 (0.58) | NOX1SNCABCHEMEN1MAPK1 | |
| SCHEMBL29188165 | 0.79 | NOX1 (0.58) | NOX1SNCABCHEMEN1MAPK1 | |
| SCHEMBL29850660 | 0.79 | NOX1 (0.58) | NOX1SNCABCHEMEN1MAPK1 | |
| Ammonia Solution, Strong SCHEMBL1927787 | 0.77 | NOX1 (0.56) | NOX1SNCABCHEMEN1MAPK1 | |
| Hydrochloric Acid SCHEMBL1929442 | 0.77 | NOX1 (0.56) | NOX1SNCABCHEMEN1MAPK1 | |
| SCHEMBL1208061 | 0.76 | MAPK1 (0.67) | NOX1SNCABCHEMEN1MAPK1 | |
| SCHEMBL1926804 | 0.76 | NOX1 (0.54) | NOX1SNCABCHEMEN1MAPK1 | |
| SCHEMBL29557693 | 0.76 | MAPK1 (0.67) | NOX1SNCABCHEMEN1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9590190-B2 | Terminally activated delayed fluorescence material, a method of synthesizing the same and an OLED device using the same | SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD (CN) | 2017-03-07 | — | — | US | disclosed |
| US-9590190-B2 | Terminally activated delayed fluorescence material, a method of synthesizing the same and an OLED device using the same | SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD (CN) | 2017-03-07 | — | — | US | disclosed |
| US-20150270494-A1 | Terminally Activated Delayed Fluorescence Material, A Method Of Synthesizing The Same and An OLED Device Using The Same | Shenzhen China Star Optoelectronics Technology Co. Ltd. (CN) | 2015-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150270494-A1 | Terminally Activated Delayed Fluorescence Material, A Method Of Synthesizing The Same and An OLED Device Using The Same | OCIAD1, OCIAD2, OGFOD1 | NOX1 901/4885SNCA 1416/4885BCHE 4323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.